Houston Personal Injury Lawyer

PULASKI & MIDDLEMAN, L.L.C. IS CURRENTLY HANDLING INDIVIDUAL CLAIMS FOR THE FOLLOWING RECENT DRUG AND MEDICAL DEVICE DEVELOPMENTS.

The explosion that rocked an Imperial Sugar processing plant in Port Wentworth, Ga. last week has claimed a confirmed six lives, with two workers still missing among the rubble in places rescue crews are still unable to reach. More than 30 people were also taken to hospitals, where many were in critical condition.


A nationwide recall for Eye Drops and Eye/Ear Wash produced and distributed by NuCel Labs has been issued. NuCel Labs, an Idaho Falls-based company, has voluntarily recalled approximately 500 units of its eye drops product following an FDA inspection which found bacteria and particulate matter in the product and declared it non-sterile.


There have been 28 reported incidents of infants and young children falling from the Bumbo Baby seat. Out of these injuries, three have been skull fractures. There over 1 million Bumbo "baby sitter" seats that have been sold by Bumbo International of South Africa.


Medtronics has stopped selling the popular lead wire used with defibrillators as the lead may tear inside the body. Approximately 235,000 patients worldwide may be affected by the Fridley-based company’s actions.


Depakote or valproate semisodium or divalproex is a drug to treat manic episodes or bipolar disorders. According to the Food and Drug association there are many dangerous side effects of Dapakote that involve the unborn Fetus.


Nephrogenic Systemic Fibrosis (NSF) is a progressive disorder which has only been seen in those with chronic kidney problems or impaired renal function. It is associated with scarring of the skin and connective tissue throughout the body, known as fibrosis. The skin thickens and becomes hard, rigid and coarse, which severely restricts movement of the joints. It can also lead to widespread fibrosis of other organs and in some cases lead to death.


Over 100 users of a recalled contact lens solution have come down with a rare and potentially blinding eye infection. At least 138 contact lens wearers, most of them users of AMO Complete Moisture Plus Multi-Purpose Solution, are believed to have contracted acanthamoeba keratitis, an infection associated with a parasite found in soil and fresh water but that rarely targets humans.


Paxil (Generic: Paroxetine hci) has been linked with suicide, suicidal ideation and violence in children and teenagers. On May 12, 2006, the FDA issued a Paxil warning when results of a study became public showing that Paxil also increases suicide risk in young adults aged 18-30.


November 10, 2005— The FDA warned women using the Ortho Evra birth control patch were at a higher risk for blood clots. The agency announced that the labeling on the medication will be updated to reflect this latest warning.


The Composix Kugel Mesh Patch is manufactured by Davol, Inc. (parent company: C.R. Bard, Inc.) and used in hernia surgery repair. Problems with the "memory recoil ring" that opens the Composix Kugel Mesh Patch can break under the stress of placement of the large sized products in the intra-abdominal space. This can lead to bowel perforations and/or chronic intestinal fistulae, or abnormal connections or passageways between the intestines and other organs. There have numerous reports of severe abdominal pain resulting from pieces of the Kugel patch adhering to patients' bowels or perforated bowels, resulting in the need for bowel dissection surgery to remove the patch and repair the bowels.


TRASYLOL: Is commonly administered to patients during heart surgery to control blood loss, has been shown to cause adverse, and even fatal side effects. A study released in January of 2006 in the New England Journal of Medicine highlighted the adverse Trasylol side effects that were previously unknown by health professionals and heart surgery patients. Trasylol side effects that were found evident in an alarming pattern among patients included a significantly increased risk of heart attacks, strokes, kidney failure, and heart failure.


Problems associated with the antibiotic Ketek (Generic: Telithromycin) were first reported in January of 2006 when researchers released information about three cases of severe liver problems in patients at a North Carolina hospital. After being treated with Ketek, the patients began to suffer health complications and had to be hospitalized. The liver problems aggrievated by the use of Ketek claimed the life of one of the patients, prompting a Federal investigation.


On May 1, 2006, Bristol-Myers Squibb stated that it will cease making and selling its antibiotic Tequin. Tequin has been linked to serious cases of diabetes and other potentially fatal blood sugar abnormalities. According to a Canadian study that was supposed to appear in the New England Journal of Medicine in March, Tequin users had 17 times greater risk of developing serious diabetes and 4 times greater risk of being hospitalized with low blood sugar complications than patients using other antibiotics.


Many patients with degenerative disc disease who chose to have a Johnson & Johnson Charité spinal disc implanted are now finding that they have increased pain or similar pain levels as compared to before the operation and little improvement in their motion abilities. Some patients are being required to have life-threatening revision surgeries.


On April 10, 2006, Bausch & Lomb announced suspension of shipments of its contact solution ReNu with MoistureLoc. Reports of fungal keratitis infections in users of the solution are surfacing in contact lens wearers who use ReNu with MoistureLoc.


Fosamax (Generic: Alendronate), manufactured by Merck, gained FDA approval in 1995. Fosamax is prescribed to treat osteoporosis and Paget's disease. Fosamax is a type of drug known as bisphosphonates. Individuals using Fosamax or other bisphosphonates should attempt to steer clear of tooth extractions and other major dental work while on the drugs.


Seroquel is an oral medication used to manage the symptoms of schizophrenia including: delusions, thought disorder, hallucinations, social withdrawal,lack of energy, apathy, and reduced ability to express emotion. Seroquel affects a broad range of neurotransmitter receptors, including serotonin receptors.


A public health advisory on Duragesic (fentanyl) was issued on July 15, 2005 by the U.S. Food and Drug Administration while the agency was investigating about 120 deaths that may have been related to the use of the transdermal pain patches.


On October 30, 2003, the FDA released an advisory about adverse events associated with Cordis Corp.'s Cypher Coronary Stent. The stent is a cylindrical metal mesh used in patients undergoing angioplasty. It works by opening clogged coronary arteries. While many patients have been treated with the Cypher stent without complications, the FDA has increasingly received reports of thrombosis, or clotting. There are now more than 290 reports of thrombosis. Typical complications start within a one to thirty day period following the procedure during which the device is implanted. In more than sixty of the reports received by the FDA, the patients suffered death associated with the stent. The other cases involved injury and medical and/or surgical intervention. The FDA has also received more than 50 reports (including some deaths) that involve hypersensitivity reactions. The symptoms include: pain, rash, respiratory alterations, hives, itching, fever, and blood pressure changes. The cause of these adverse events has not yet been determined.


Pulaski &Middleman, L.L.C. filed one of the first lawsuits in the United States against Guidant Corp. related to this recall.On June 17, 2005 Guidant Corp. recalled nearly 50,000 of its cardiac defibrillators implanted in patients worldwide because of defects that could lead to serious injury and death. It is believed that approximately 38,000 defibrillators have been implanted in patients in the United States. The defective Guidant models are: Prizm 2 DR, the Contak Renewal and Contak Renewal 2, the Ventak Prizm AVT, Vitality AVT, Renewal 3 AVT and Renewal 4 AVT ICDs. Guidant Corp. failed to inform doctors or patients for three years that some of their defibrillators had a defect that caused the devices to short-circuit. Less than one week later Guidant issued its second safety advisory about its implantable defibrillators. Guidant told doctors to stop using five of the models because they could malfunction because of a defective switch. The latest warning applies to Guidant's Contak Renewal 3 and 4 models, Renewal RF model and the Renewal 3 and 4 AVT devices, which were included in the June 17 safety advisory.




Zyprexa, used to treat schizophrenia, bi-polar, ADHD and other mental disorders, has been linked to diabetes and diabetes related complications including coma and death. PULASKI AND MIDDLEMAN ARE NO LONGER ACCEPTING NEW CASES RELATED TO ZYPREXA.